Skip to content
Open access · CC-BY via OpenAlex

Emerging Therapeutic Potential of Fisetin for Nephrotoxicity, Kidney Injury, and Nephropathy: A Systematic Review

Saeed Mohajeri, Alizamen Salehifard Jouneghani, Saeid Heidari-Soureshjani, Catherine M.T. Sherwin, Faramarz Mohammad Ali Beigi

Current Diabetes Reviews · 2025 · ▲ 2 citations

Abstract

INTRODUCTION/OBJECTIVE: Kidney diseases cause high morbidity and mortality worldwide. This study investigated the mechanistic effects of Fisetin (FIS) on nephrotoxicity, kidney injury, and nephropathy induced by drugs, toxic chemicals, diabetes, lupus, diet, ureteral obstruction, and ischemic situations. METHODS: To identify pertinent articles published before Oct 1, 2024, a comprehensive electronic search was performed across several databases, including MEDLINE/PubMed, Embase, Cochrane Library, Web of Science, and Scopus. After establishing clear inclusion and exclusion criteria, studies that met the research objectives were selected. Data were extracted and analyzed, documenting study characteristics, methodologies, and biological mechanisms. RESULTS AND DISCUSSION: Antioxidant benefits were evident with increased levels of endogenous antioxidant enzymes and NQO1, alongside reduced oxidative stress markers such as 8-OHdG and MDA. Enhanced mitochondrial function, including improved respiration, ATP synthesis, and antioxidant capacity, further supported cellular resilience. Anti-inflammatory effects were marked by reduced pro-inflammatory cytokines, macrophage and neutrophil infiltration, and inhibited pathways like NF-κB and MAPK. Anti-apoptotic actions included decreased levels of pro-apoptotic proteins. FIS also reduced fibrotic markers and pathways such as TGF-β/SMAD, mitigating excessive ECM buildup. Additionally, modulation of metabolic pathways was observed, including decreased glucose and lipid profiles and improved insulin sensitivity. Kidney function and structural integrity were preserved with reduced levels of nephrotoxic agents. CONCLUSION: Preclinical studies revealed that FIS demonstrates promising protective effects against kidney toxicity, renal injury, diabetes, and lupus-induced nephropathy. However, more clinical studies are needed in this field to determine effective and safe doses.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.2174/0115733998369114250512094027
Canonical
link ↗
Fetched
2026-11-09 MST

Cite this

APA
Mohajeri, S., Jouneghani, A.S., Heidari-Soureshjani, S., Sherwin, C.M., &amp; Beigi, F.M.A. (2025). Emerging Therapeutic Potential of Fisetin for Nephrotoxicity, Kidney Injury, and Nephropathy: A Systematic Review. <em>Current Diabetes Reviews</em>. https://doi.org/10.2174/0115733998369114250512094027
Vancouver
Mohajeri S, Jouneghani AS, Heidari-Soureshjani S, Sherwin CM, Beigi FMA. Emerging Therapeutic Potential of Fisetin for Nephrotoxicity, Kidney Injury, and Nephropathy: A Systematic Review. Current Diabetes Reviews. 2025. doi:10.2174/0115733998369114250512094027.
BibTeX
@article{saeed2025Emergi, title = {Emerging Therapeutic Potential of Fisetin for Nephrotoxicity, Kidney Injury, and Nephropathy: A Systematic Review}, author = {Saeed Mohajeri and Alizamen Salehifard Jouneghani and Saeid Heidari-Soureshjani and Catherine M.T. Sherwin and Faramarz Mohammad Ali Beigi}, journal = {Current Diabetes Reviews}, year = {2025}, doi = {10.2174/0115733998369114250512094027}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings